Clinical Trial Update: Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, the effect of food, safety and tolerability of a new tablet formulation of GSK1144814 in healthy subjects. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• GSK1144814

Snippet

Sponsor: GlaxoSmithKline | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED